Reaction Details Report a problem with these data
Target
Platelet-activating factor receptor
Ligand
BDBM50011853
Substrate
n/a
Meas. Tech.
ChEBML_154999
IC50
30±n/a nM
Citation
 Walser, A; Flynn, T; Mason, C; Crowley, H; Maresca, C; O'Donnell, M Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2. J Med Chem 34:1440-6 (1991) [PubMed]  Article 
Target
Name:
Platelet-activating factor receptor
Synonyms:
PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39219.60
Organism:
Homo sapiens (Human)
Description:
PAF Platelet activating factor PTAFR HUMAN::P25105
Residue:
342
Sequence:
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKGSVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAVFIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKFRKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
  
Inhibitor
Name:
BDBM50011853
Synonyms:
4-(2-Chloro-phenyl)-2-[2-(4-isobutyl-phenyl)-ethyl]-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene | CHEMBL32942
Type:
Small organic molecule
Emp. Form.:
C27H27ClN4S
Mol. Mass.:
475.048
SMILES:
CC(C)Cc1ccc(CCc2cc3c(s2)-n2c(C)nnc2CN=C3c2ccccc2Cl)cc1 |c:24|
Structure:
Search PDB for entries with ligand similarity: